MS Pharma Takes MENA Rights To Lucentis Rival

Company Will Register And Market Bioeq-Formycon FYB201 Ranibizumab Candidate

 
• By Dave Wallace
  
Eye Close-Up Africa Pupil
MS Pharma has rights to ranibizumab in North Africa and the Middle East • Source: Alamy

More from Deals

More from Business